Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Armata Pharmaceuticals, Inc. | armp-20201231ex322242b55.htm |
| EX-32.1 - EX-32.1 - Armata Pharmaceuticals, Inc. | armp-20201231ex321f1ac6e.htm |
| EX-31.2 - EX-31.2 - Armata Pharmaceuticals, Inc. | armp-20201231ex312884e04.htm |
| EX-31.1 - EX-31.1 - Armata Pharmaceuticals, Inc. | armp-20201231ex311a990ac.htm |
| EX-21.1 - EX-21.1 - Armata Pharmaceuticals, Inc. | armp-20201231ex21148ae91.htm |
| EX-4.9 - EX-4.9 - Armata Pharmaceuticals, Inc. | armp-20201231ex49554cb71.htm |
| 10-K - 10-K - Armata Pharmaceuticals, Inc. | armp-20201231x10k.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements of Armata Pharmaceuticals, Inc.:
| (1) | Registration Statements (Form S-1 Nos. 333-213421, 333-217169, 333-217680, and 333-226959), |
| (2) | Registration Statements (Form S-3 Nos. 333-210974, 333-237533 and 333-237534), |
| (3) | Registration Statement (Form S-8 No. 333-203455) pertaining to the 2012 Stock Incentive Plan and 2013 Stock Incentive Plan, |
| (4) | Registration Statements (Form S-8 Nos. 333-212183, 333-217563 and 333-223987) pertaining to the Armata Pharmaceuticals, Inc. 2016 Employee Stock Purchase Plan and Armata Pharmaceuticals, Inc. 2016 Equity Incentive Plan, |
| (5) | Registration Statements (Form S-8 Nos. 333-221564 and 333-232058) pertaining to the Armata Pharmaceuticals, Inc. 2016 Equity Incentive Plan, as amended, C3J Jian, Inc. Amended 2006 Stock Option Plan and C3J Therapeutics, Inc. 2016 Stock Plan, and |
| (6) | Registration Statement (Form S-8 No. 333-250034) pertaining to the Inducement Restricted Stock Unit Award (October 2020); |
of our report dated March 18, 2021, with respect to the consolidated financial statements of Armata Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Armata Pharmaceuticals, Inc. for the year ended December 31, 2020.
/s/ Ernst & Young LLP
San Diego, California
March 18, 2021